These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 2936652)
1. Thymoxamine: a miotic for intraocular use. Grehn F; Fleig T; Schwarzmüller E Graefes Arch Clin Exp Ophthalmol; 1986; 224(2):174-8. PubMed ID: 2936652 [TBL] [Abstract][Full Text] [Related]
2. Intraocular thymoxamine or acetylcholine for the reversal of mydriasis. Pfeiffer N; Grehn F; Wellek S; Schwenn O Ger J Ophthalmol; 1994 Nov; 3(6):422-6. PubMed ID: 7866263 [TBL] [Abstract][Full Text] [Related]
3. Thymoxamine and intraocular pressure. Bonomi L; Tomazzoli L Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1977 Oct; 204(2):95-100. PubMed ID: 145190 [TBL] [Abstract][Full Text] [Related]
4. Thymoxamine hydrochloride: an alpha-adrenergic blocker. Wand M; Grant WM Surv Ophthalmol; 1980; 25(2):75-84. PubMed ID: 6108620 [TBL] [Abstract][Full Text] [Related]
5. [Reduction of endothelial cell number by cataract operation with intraocular thymoxamine administration. A randomized, double-blind study]. Schwenn OK; Schellein O; Pfeiffer N; Grehn F Ophthalmologe; 1997 Feb; 94(2):136-40. PubMed ID: 9156638 [TBL] [Abstract][Full Text] [Related]
6. The effects of thymoxamine on anterior chamber depth in human eyes. Susanna R; Drance SM; Schulzer M; Douglas GR Can J Ophthalmol; 1978 Oct; 13(4):250-1. PubMed ID: 154360 [TBL] [Abstract][Full Text] [Related]
7. [Preliminary study of the topical use of thymoxamine]. Reibaldi A; Lograno MD; Mininno L; Avitabile T Boll Soc Ital Biol Sper; 1982 Aug; 58(15):991-6. PubMed ID: 6215049 [TBL] [Abstract][Full Text] [Related]
8. Effect of thymoxamine on the human pupil. Lee DA; Rimele TJ; Brubaker RF; Nagataki S; Vanhoutte PM Exp Eye Res; 1983 May; 36(5):655-62. PubMed ID: 6221938 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effect of thymoxamine solution 0.5% on mydriasis induced by ibopamine solution 1%. Drago F; Dal Bello A; Marino V; Pisati R; Lodola E; Barbieri P Eur J Clin Pharmacol; 1993; 44(5):477-80. PubMed ID: 8359186 [TBL] [Abstract][Full Text] [Related]
10. The influence of iris pigmentation on the miotic effect of thymoxamine. Diehl DL; Robin AL; Wand M Am J Ophthalmol; 1991 Mar; 111(3):351-5. PubMed ID: 1825744 [TBL] [Abstract][Full Text] [Related]
11. Thymoxamine test. Differentiating angle-closure glaucoma form open-angle glaucoma with narrow angles. Wand M; Grant WM Arch Ophthalmol; 1978 Jun; 96(6):1009-11. PubMed ID: 148879 [TBL] [Abstract][Full Text] [Related]
12. Thymoxamine in the treatment of traumatic mydriasis. Sharma A; Votruba M Br J Ophthalmol; 1993 Oct; 77(10):681. PubMed ID: 8218044 [No Abstract] [Full Text] [Related]
16. Retrospective assessment of thymoxamine (Opilon) in treatment of Ménières disease. Young JR J Int Med Res; 1978; 6(2):166-8. PubMed ID: 147192 [TBL] [Abstract][Full Text] [Related]
17. [The alpha-adrenergic effect of thymoxamine on the vessels of the ciliary body]. Virno M; Pecori-Giraldi J; Pellegrino N; Planner-Terzaghi A Klin Monbl Augenheilkd; 1983 Oct; 183(4):270-2. PubMed ID: 6316023 [TBL] [Abstract][Full Text] [Related]
18. [Thymoxamine and angle-closure glaucoma]. Etienne R J Fr Ophtalmol; 1983; 6(12):971-4. PubMed ID: 6232307 [TBL] [Abstract][Full Text] [Related]
19. The effect of phenylephrine hydrochloride on the miotic-treated eye. BECKER B; GAGE T; KOLKER AE; GAY AJ Am J Ophthalmol; 1959 Sep; 48():313-21. PubMed ID: 13798060 [No Abstract] [Full Text] [Related]
20. The use of thymoxamine in eyelid retraction. Dixon RS; Anderson RL; Hatt MU Arch Ophthalmol; 1979 Nov; 97(11):2147-50. PubMed ID: 159683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]